Finance
Cancer Prevention
Health

Enochian Biosciences

$4.71
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.03 (-0.63%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell ENOB and other stocks, options, ETFs, and crypto commission-free!

About ENOB

Enochian Biosciences, Inc. engages in the development of vaccine for treatment of infectious diseases and cancer. Its pipeline consists of ENO-1001, ENO-2001, ENO-3001, ENO-4002 and ENO-4001. Read More The company was founded by Rene Sindlev on January 18, 2011 and is headquartered in Horsholm, Denmark. ENOB is listed on the OTCQB market tier. OTC market data is provided by OTC Markets Group, Inc (otcmarkets.com).

Employees
4
Headquarters
Los Angeles, California
Founded
2011
Market Cap
182.70M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
29.15K
High Today
$4.76
Low Today
$4.70
Open Price
$4.76
Volume
15.80K
52 Week High
$9.50
52 Week Low
$3.70

Collections

Finance
Cancer Prevention
Health
2018 IPO
US
North America
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.